Figure 6.
Figure 6. Myr-Arf6 peptide inhibits F-actin formation. Washed platelets were treated with DMSO (A) or 25 μM myr-Arf6 (B), myr-Arf1 (C), or nonmyr-Arf6 (D) peptides for 5 minutes at 37°C. After washing, the platelets were allowed to bind to collagen-coated coverslips for 10 minutes at 37°C, fixed with 3.7% formaldehyde, and quenched with 50 mM NH4Cl. TRITC-conjugated phalloidin in 10% FBS/PBS with 0.2% saponin was used to stain for F-actin. Images were taken using a SPOT CCD camera, model 9.0 monochrome-6 (Diagnostic Instruments, Sterling Heights, MI) and processed using SPOT Advanced software, version 4.1.1 (Diagnostic Instruments). Only contrast and brightness were adjusted with Photoshop 7.0 software (Adobe, San Jose, CA).

Myr-Arf6 peptide inhibits F-actin formation. Washed platelets were treated with DMSO (A) or 25 μM myr-Arf6 (B), myr-Arf1 (C), or nonmyr-Arf6 (D) peptides for 5 minutes at 37°C. After washing, the platelets were allowed to bind to collagen-coated coverslips for 10 minutes at 37°C, fixed with 3.7% formaldehyde, and quenched with 50 mM NH4Cl. TRITC-conjugated phalloidin in 10% FBS/PBS with 0.2% saponin was used to stain for F-actin. Images were taken using a SPOT CCD camera, model 9.0 monochrome-6 (Diagnostic Instruments, Sterling Heights, MI) and processed using SPOT Advanced software, version 4.1.1 (Diagnostic Instruments). Only contrast and brightness were adjusted with Photoshop 7.0 software (Adobe, San Jose, CA).

Close Modal

or Create an Account

Close Modal
Close Modal